What’s New in Pancreatic Cancer Treatment: 8 Emerging Therapies to Watch Out For
Evolving Treatment Landscape of Pancreatic Cancer: Pancreatic cancer remains one of the most challenging cancers to treat, characterized by its late diagnosis and resistance to conventional therapies. As the search for effective treatments continues, several emerging therapies show promise in advancing pancreatic cancer treatment . Pancreatic Cancer Emerging Therapies: Here are the top 8 emerging therapies to watch in the fight against pancreatic cancer: 1. PARP Inhibitors PARP inhibitors, such as olaparib and rucaparib, target DNA repair mechanisms in cancer cells. These drugs are showing potential in treating pancreatic cancer, particularly in patients with BRCA mutations. By disrupting cancer cell repair, PARP inhibitors can enhance the efficacy of chemotherapy. 2. Immunotherapy Immunotherapy, including checkpoint inhibitors like pembrolizumab and nivolumab, aims to boost the body's immune response against pancreatic cancer cells. While still in the clinical trial phase, the